EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Nonvitamin K Anticoagulants: Risk of Bleeding When Interacting With Other Medications: A Cohort Study From Medicare

Ainhoa Gomez-Lumbreras, Madeline Brendle, Krystal Moorman-Bishir, Malinda Tan, Daniel C Malone

Clinical Cardiology · 2024-10 · 47 (10)

DOI: 10.1002/clc.70023 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Cardiology, online erschienen am 03.10.2024. Verfasst von Ainhoa Gomez-Lumbreras und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Medicare, Anticoagulants, Gastrointestinal Hemorrhage, Drug Interactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was conducted with a grant from the Alsam Foundation (PI Daniel C Malone). The ALSAM Foundation Grant 2021..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients on nonvitamin K antagonist (NVKA) are usually taking other drugs. Potential interaction may increase the gastrointestinal (GI) bleeding risk associated with NVKA.

Methods

Observational cohort study using Medicare data from 2017 to 2020. Participants receiving a NVKA were included. A concomitant overlapping period while on NVKA was assessed for nonsteroidal anti‐inflammatory drugs (NSAIDS), selective serotonin reuptake inhibitors (SSRI), antiplatelets, glucocorticoids, aspirin and proton pump inhibitors (PPI). A logistic regression predicting either any bleeding or GI bleeding was conducted estimating the odds ratio (OR) and 95% confidence interval (CI).

Results

A total of 102 531 people on NVKA with mean age 77 years (SD = 9.8) and 55% females ( N = 56 671) were included. Previous history of GI bleeding occurred in 2 908 (2.8%) participants, concomitant exposure to PPI occurred in 38 713 (38%), SSRI in 16 487 (16%), clopidogrel in 15 795 (15.4%), NSAIDs in 13 715 (13.4%) and glucocorticoids in 13 715 (13.4%). Risk for any bleeding was shown for clopidogrel (OR: 1.37, 95% CI: 1.30, 1.44), prasugrel/ticagrelor (OR: 1.36, 95% CI: 1.18, 1.58), glucocorticoids (OR: 1.26, 95% CI: 1.19, 1.34), and SSRIs (OR: 1.13, 95% CI: 1.07, 1.19). GI bleeding risk was shown for clopidogrel (OR: 1.44, 95% CI: 1.34, 1.55), prasugrel/ticagrelor (OR: 1.47, 95% CI: 1.20, 1.79), SSRIs (OR: 1.09, 95% CI: 1.01, 1.17) and glucocorticoids (OR: 1.33, 95% CI: 1.23, 1.44). PPI use was correlated with both NSAID ( r = 0.07, p ≤ 0.0001) and SSRI use ( r = 0.09, p ≤ 0.0001).

Conclusion

NVKA concomitantly taken with antiplatelets, glucocorticoids, and SSRIs showed an increased risk for any bleeding and GI bleeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicareAnticoagulantsGastrointestinal HemorrhageDrug InteractionsHumansFemaleMaleAgedUnited StatesRisk FactorsRisk AssessmentRetrospective StudiesAged, 80 and overProton Pump InhibitorsIncidencePlatelet Aggregation InhibitorsSelective Serotonin Reuptake Inhibitors

Stichwörter der Autor:innen

drug interactionsfactor Xa inhibitorsgastrointestinal hemorrhagehemorrhagerisk factors

Substanzen

AnticoagulantsProton Pump InhibitorsPlatelet Aggregation InhibitorsSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.
  • Department of Health Outcomes, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.
  • Real World Evidence, Open Health, Bethesda, Maryland, USA.

Förderung

  • This research was conducted with a grant from the Alsam Foundation (PI Daniel C Malone). The ALSAM Foundation Grant 2021.

Zitieren

APA

Gomez-Lumbreras, A., Brendle, M., Moorman-Bishir, K., Tan, M., & Malone, D. C. (2024). Nonvitamin K Anticoagulants: Risk of Bleeding When Interacting With Other Medications: A Cohort Study From Medicare. Clinical Cardiology, 47(10). https://doi.org/10.1002/clc.70023

Vancouver

Gomez-Lumbreras A, Brendle M, Moorman-Bishir K, Tan M, Malone DC. Nonvitamin K Anticoagulants: Risk of Bleeding When Interacting With Other Medications: A Cohort Study From Medicare. Clinical Cardiology. 2024;47(10). doi:10.1002/clc.70023

BibTeX
@article{GomezLumbreras2024,
  author = {Gomez-Lumbreras, Ainhoa and Brendle, Madeline and Moorman-Bishir, Krystal and Tan, Malinda and Malone, Daniel C},
  title = {Nonvitamin K Anticoagulants: Risk of Bleeding When Interacting With Other Medications: A Cohort Study From Medicare},
  journal = {Clinical Cardiology},
  year = {2024},
  volume = {47},
  number = {10},
  doi = {10.1002/clc.70023}
}
Kostenlos starten →